Table 2.

Details of three cases of acute pseudophakic cystoid macular edema treated with nepafenac 0.1%

Case	Pre-treatment retinal thickness (μm)	Post-treatment retinal thickness (μm)	Retinal thickness improvement (μm)	Pre-treatment VA (logMAR VA)	Post-treatment VA (logMAR VA)	VA improvement (logMAR)	Treatment
#6	448	211	237	20/50 (0.40)	20/30 (0.18)	0.22	Nepafenac 0.1% TID and prednisolone acetate 1% QID 8 weeks
#7	380	236	144	20/80 (0.60)	20/80 (0.60)	0	Nepafenac 0.1% TID 4 weeks
#8	306	284	22	20/40 (0.30)	20/30 + 2 (0.14)	0.16	Nepafenac 0.1% TID 10 weeks
Total mean data ± SD	378 ± 71.0	244 ± 40.4	134 ± 111.0	0.43 ± 0.15	0.31 ± 0.25	0.13 ± 0.11

Abbreviations: QID, four times daily; SD, standard deviation; TID, three times daily; VA, visual acuity.